Trial completion date • IO biomarker • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • PGR (Progesterone receptor) • TMB (Tumor Mutational Burden)
|
HR positive • HER-2 amplification • HER-2 negative • ER positive + PGR positive • PGR positive
|
MSK-IMPACT • OncoPanel™ Assay
|
Opdivo (nivolumab) • Yervoy (ipilimumab)